Equity Overview
Price & Market Data
Price: $2.45
Daily Change: -$0.11 / 4.49%
Daily Range: $2.44 - $2.79
Market Cap: $2,722,366
Daily Volume: 39,340
Performance Metrics
1 Week: -14.04%
1 Month: -54.92%
3 Months: -68.44%
6 Months: -73.66%
1 Year: -87.26%
YTD: -55.45%
Company Details
Employees: 7
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Glen Allen, Virginia.